Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Sleep and Breathing
Published in: Sleep and Breathing 4/2020

01-12-2020 | Polysomnography | Sleep Breathing Physiology and Disorders • Letter to the Editors

Unexpected pressure swings in a positive airway pressure device: an unknown cause for bad CPAP tolerance?

Authors: Charlotte Mauclet, Giuseppe Liistro, Daniel Rodenstein, Myriam Dury, Valérie-Anne Chantrain, Gimbada Benny Mwenge

Published in: Sleep and Breathing | Issue 4/2020

Login to get access

Excerpt

To the Editors, …
Literature
1.
Sullivan CE, Issa FG, Berthon-Jones M, Eves L (1981) Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet 1(8255):862–865CrossRef
2.
Jackson M, King MA, Shneerson JM (1992) Inter-machine variability in the stability of continuous positive airway pressure. Eur Respir J 5(5):587–591PubMed
3.
Netzer N, Kirbas G, Matthys H, Werner P (1997) Technical differences in various CPAP and BiLevel CPAP devices. Pneumologie 51(3):789–795PubMed
4.
Demirozu MC, Chediak AD, Nay KN, Cohn MA (1991) A comparison of nine nasal continuous positive airway pressure machines in maintaining mask pressure during simulated inspiration. Sleep 14(3):259–262PubMed
Metadata
Title
Unexpected pressure swings in a positive airway pressure device: an unknown cause for bad CPAP tolerance?
Authors
Charlotte Mauclet
Giuseppe Liistro
Daniel Rodenstein
Myriam Dury
Valérie-Anne Chantrain
Gimbada Benny Mwenge
Publication date
01-12-2020
Publisher
Springer International Publishing
Keyword
Polysomnography
Published in
Sleep and Breathing / Issue 4/2020
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-019-01938-9

Other articles of this Issue 4/2020

Sleep and Breathing 4/2020 Go to the issue

Sleep Breathing Physiology and Disorders • Letter to the Editors

Sleep disturbances and nicotine addiction:a bidirectional relationship?

ENT • Original Article

Effectiveness of sleep surgery versus a mandibular advancement device for obstructive sleep apnea in terms of nocturnal cardiac autonomic activity

Sleep Breathing Physiology and Disorders • Letter to the Editors (Invited)

Role of CD3+γδ-T cells in the association of obstructive sleep-disordered breathing and cancer

Psychiatrics • Original Article

Sleep disturbance is associated with an increased risk of menstrual problems in female Chinese university students

Sleep Breathing Physiology and Disorders • Letter to the Editors

Efficacy of positional therapy in treatment of patients with obstructive sleep apnea: a pilot study

Sleep Breathing Physiology and Disorders • Original Article

Electrical stimulation of the whole hypoglossal nerve in patients with obstructive sleep apnea
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits